Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Church

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pathology|July 24, 2015
Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysisRichard Colling, David N Church, Juliet Carmichael, et al.
American Journal of Clinical Oncology|June 6, 2008
Extended survival in women with brain metastases from HER2 overexpressing breast cancerDavid N Church, Ramayana Modgil, Sam Guglani, et al.
Scientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
BMJ Oncology|January 31, 2025
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacyNeil Ryan, Mark Glaire, Thomas Walker, et al.
The Journal of Pathology|March 9, 2022
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escapeMark A Glaire, Neil Aj Ryan, Marieke E Ijsselsteijn, et al.
EMBO Molecular Medicine|August 17, 2023
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesisMatthew Brown, Alicia Leon, Katarzyna Kedzierska, et al.
Oncoimmunology|September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancerFenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Cancers|September 28, 2021
Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different AetiologiesNeil A J Ryan, Thomas D J Walker, James Bolton, et al.
Clinical Genitourinary Cancer|June 22, 2016
Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular TumorsKarin Purshouse, Robert A Watson, David N Church, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pathology|July 24, 2015
Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysisRichard Colling, David N Church, Juliet Carmichael, et al.
American Journal of Clinical Oncology|June 6, 2008
Extended survival in women with brain metastases from HER2 overexpressing breast cancerDavid N Church, Ramayana Modgil, Sam Guglani, et al.
Scientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
BMJ Oncology|January 31, 2025
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacyNeil Ryan, Mark Glaire, Thomas Walker, et al.
The Journal of Pathology|March 9, 2022
Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escapeMark A Glaire, Neil Aj Ryan, Marieke E Ijsselsteijn, et al.
EMBO Molecular Medicine|August 17, 2023
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesisMatthew Brown, Alicia Leon, Katarzyna Kedzierska, et al.
Oncoimmunology|September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancerFenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Cancers|September 28, 2021
Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different AetiologiesNeil A J Ryan, Thomas D J Walker, James Bolton, et al.
Clinical Genitourinary Cancer|June 22, 2016
Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular TumorsKarin Purshouse, Robert A Watson, David N Church, et al.
Pageof 7